AZULFIDINE

LOE Approaching

sulfasalazine

NDAORALTABLET
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

CLINICAL PHARMACOLOGY Pharmacodynamics The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), may be related to the anti-inflammatory and/or immunomodulatory properties that have been observed in animal and in vitro models, to its…

Clinical Trials (5)

NCT05445440Phase 1Completed

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

Started Sep 2022
30 enrolled
Healthy Participants
NCT04720183Phase 1Completed

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

Started Jan 2021
8 enrolled
Healthy
NCT03801733Phase 1Completed

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

Started Jun 2018
NCT01689532Phase 3Completed

A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine

Started Nov 2012
122 enrolled
Arthritis, Rheumatoid
NCT01198145Phase 3Completed

Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy

Started Apr 2011
87 enrolled
DiarrheaGastrointestinal ComplicationsUnspecified Adult Solid Tumor, Protocol Specific